Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Takeda claims novel tyrosine kinase inhibitors

April 17, 2009

Pro-Pharmaceuticals' Davanat was not associated with mucositis in phase I and II trials

April 16, 2009

First human pharmacokinetic data for anticancer agent KP-1019 reported

April 16, 2009

Novel MEK inhibitors identified by Curis

April 16, 2009

Sanofi-aventis to acquire BiPar Sciences

April 15, 2009

FDA grants orphan drug designation for Paclical in ovarian cancer

April 15, 2009

Bayer describes novel substituted tricyclic compounds for cancer treatment

April 15, 2009

Novel cytotoxic xanthone compounds claimed by Bristol-Myers Squibb

April 15, 2009

Cell Therapeutics initiates rolling NDA for pixantrone

April 14, 2009

Myriad receives IND approval for new cancer drug, MPC-3100

April 14, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...